Research Roundup

Debbie Rigby presents the latest research news relevant to pharmacists Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillationA sub-hoc analysis of the ARISTOTLE trial has shown three-quarters of patients had polypharmacy; and this subgroup had an increased comorbidity, more interacting drugs, increased mortality, and higher rates of thromboembolic and bleeding complications.